Author(s): Ramavath Muralidhar Naik, Hindustan Abdul Ahad, Haranath Chinthaginjala, Bogavalli Varalakshmi, Siriguppa Dheeraj, Pathakumari Jaya Sree

Email(s): muralismc7@gmail.com

DOI: 10.52711/2231-5659.2024.00003   

Address: Ramavath Muralidhar Naik1*, Hindustan Abdul Ahad2, Haranath Chinthaginjala1, Bogavalli Varalakshmi1, Siriguppa Dheeraj1, Pathakumari Jaya Sree1
1Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) -Autonomous, Ananthapuramu - 515001, AP, India.
2Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) - Autonomous, Ananthapuramu - 515001, AP, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 1,     Year - 2024


ABSTRACT:
A zoonotic condition known as monkeypox (MPX) is brought on by the monkeypox virus (MPXV), a species of the orthopoxvirus family. It was found in 1958 following an epidemic at a Copenhagen, Denmark, livestock facility. MPX has a clinical appearance that is comparable to smallpox (SPX). Laterit’sfinding, MPXV has shown a tendency to infect and cause disease in a significant number of mammalian animals from all over the world. Traveller’s MPX was exported from African countries (Nigeria) to other regions of the world in 2018 and 2019, respectively, raising concerns that MPXV may have emerged to occupy the ecological and immunological niche left by the smallpox virus (SPXV). MPXV first appeared again in 2017 in Bayelsa state after 39 years with no reported cases in Nigeria. This review's goal is to locate all documented cases of human MPXepidemics and pertinent epidemiological data. We made an effort to gather and discuss in this review all articles that have been written about MPXV infections that have been found experimentally or naturally. We also go through the comparative illness courses and the state of our understanding of the biology of infection, epidemiology, diagnosis, spread, and prevention of MPXV globally, particularly concerning humans. The MPXV is regarded as a high-danger pathogen that roots a disease that is significant for public health. To plan effective preventative, preparedness, and response actions, it is vital to concentrate on developing surveillance capacities that will yield meaningful information.


Cite this article:
Ramavath Muralidhar Naik, Hindustan Abdul Ahad, Haranath Chinthaginjala, Bogavalli Varalakshmi, Siriguppa Dheeraj, Pathakumari Jaya Sree. An Outbreak of the Monkeypox Virus: An Alert to Mankind. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2024; 14(1):11-8. doi: 10.52711/2231-5659.2024.00003

Cite(Electronic):
Ramavath Muralidhar Naik, Hindustan Abdul Ahad, Haranath Chinthaginjala, Bogavalli Varalakshmi, Siriguppa Dheeraj, Pathakumari Jaya Sree. An Outbreak of the Monkeypox Virus: An Alert to Mankind. Asian Journal of Research in Pharmaceutical Sciences. Sci. 2024; 14(1):11-8. doi: 10.52711/2231-5659.2024.00003   Available on: https://ajpsonline.com/AbstractView.aspx?PID=2024-14-1-3


REFERENCES:
1.    Hobson G, Adamson J, Adler H, et al. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. 2021; 26(32):2100745.
2.    Quarleri J, Delpino M, Galvan VJG. Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries. 2022:1-9.
3.    Jain RS, Jain TG, Ishikar SKJAjom. Impact of COVID-19 on changing habits and health issues of the public. 2020; 11(4):524-528.
4.    Maheswary MJAJoNE, Research. To Assess the Knowledge of Ebola Virus Disease among Staff Nurses and Nursing Students in selected Hospital and College, Jalandhar, Punjab. 2020; 10(2):183-184.
5.    Focosi D, Novazzi F, Baj A, Maggi FJRiMV. Monkeypox: An international epidemic. 2022:e2392.
6.    Amina MS, Raju AB, Delfeena B, et al. A Study to assess the effectiveness of Structured Teaching Programme on knowledge regarding NIPAH virus infection among adolescents in selected school at Kollam. 2021; 11(3):405-408.
7.    Hatmal MmM, Al-Hatamleh MA, Olaimat AN, et al. Comprehensive Literature Review of Monkeypox. 2022(just-accepted):1-84.
8.    Kaler J, Hussain A, Flores G, Kheiri S, Desrosiers DJC. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation. 2022; 14(7).
9.    Negi ARJAJoNE, Research. Novel Coronavirus (COVID 19) Knowledge and Perception: A Survey of Healthcare workers. 2021; 11(4):503-509.
10.    Antunes F, Cordeiro R, Virgolino AJIDR. Monkeypox: From A Neglected Tropical Disease to a Public Health Threat. 2022; 14(5):772-783.
11.    Habibunisha H, Rathinam VA, Nivethitha KJAJoNE, Research. A study on perception on Covid-19 vaccination among general public. 2021; 11(4):537-540.
12.    Kabuga AI, El Zowalaty MEJJoMV. A review of the monkeypox virus and a recent outbreak of skin rash disease in Nigeria. 2019; 91(4):533-540.
13.    Murphy H, Ly HJV. The potential risks posed by inter-and intraspecies transmissions of monkeypox virus. Vol 13: Taylor & Francis; 2022:1681-1683.
14.    El Eid R, Allaw F, Haddad SF, Kanj SSJPP. Human monkeypox: A review of the literature. 2022; 18(9):e1010768.
15.    Dhandapani M, Vijay V, Krishnan N, et al. An evidence-based nursing care guide for critically ill patients with COVID-19: A scoping Review. 2022; 12(1):144-157.
16.    Bryer JS, Freeman EE, Rosenbach MJJotAAoD. Monkeypox emerges on a global scale: a historical review and dermatological primer. 2022.
17.    Mileto D, Riva A, Cutrera M, et al. New challenges in human monkeypox outside Africa: A review and case report from Italy. 2022:102386.
18.    Alakunle E, Moens U, Nchinda G, Okeke MIJV. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. 2020; 12(11):1257.
19.    Outbreaks WHOJWBo, 1-23 oE. Weekly Bulletin on Outbreak and other Emergencies: Week 34: 18-24 August 2018. 2018:1-32.
20.    Damon IKJV. Status of human monkeypox: clinical disease, epidemiology and research. 2011; 29:D54-D59.
21.    Dawood AAJAJoPA. Reasons for discontinuing the use of Hydroxychloroquine in the treatment of the Novel Coronavirus. 2021; 11(2):179-180.
22.    Forni D, Molteni C, Cagliani R, Sironi MJTJoid. Geographic structuring and divergence time frame of monkeypox virus in the endemic region. 2022.
23.    Ahad HA, Haranath C, Tarun K, Krishna JV, Chandana N, Indrani BJAJoPR. Immuno-boosters as health accelerants to tackle viral infections. 2021; 11(3):212-216.
24.    Ahad HA, Haranath C, Kumar BP, Roy D, Dharani BHS, Ayisha MUJAJoRiPS. A Desk Top Allusion to The Rare Orphan Diseases and Orphan Drugs: Possessions to Discern by Every Healthcare Professional. 2021; 11(3):247-252.
25.    Kushwaha A, Kumar A, Madhavan A, et al. Immunogenic proteins of capripox virus: Potential applications in diagnostic/prophylactic developments. 2019; 6(6):130.
26.    Ahad HA, Chinthaginjala H, Dharani BHS, et al. Country Wise Measures in Contrast to The Spread of SARS-COV2/COVID-19. 2022.
27.    Ferrareze PAG, e Costa RAP, Thompson CEJb. Genomic characterization and molecular evolution of human Monkeypox viruses. 2022.
28.    Sunitha D, Hemalatha K, Chary M, Unissa RJAJoPR. A Review on Zika Virus. 2016; 6(3):181-185.
29.    Ahad HA, Chinthaginjala H, Reddy GJ, Krishna PD, Rahamathulla S, Krishna JVJAJoRiC. Abbreviated New Drug Application Process: A Gift for The Industry and The Patients. 2021; 14(5):331-335.
30.    Ahad HA, Haranath C, Rahamathulla S, Shaikshavali S, Ayesha S, Azmathulla SJAJoRiC. Concoct Children to Combat the Third Wave of COVID-19. 2021; 14(6):455-458.
31.    Reynolds MG, Wauquier N, Li Y, et al. Human monkeypox in Sierra Leone after 44-Year absence of reported cases. 2019; 25(5):1023.
32.    Kumar R, Saini S, Singh C, Singh B, Saifi AJAJoPR. Ebola Virus: A Review. 2020; 10(2):117-119.
33.    Onyeme A. Strategic measures for accessing effective healthcare delivery in rural Nigeria, Loughborough University; 2019.
34.    Fouziya B, Ahad HA, Charan DS, et al. Fabrication and Evaluation of Cefpodoxime Proxetil Niosomes. 2022; 12(2):109-112.
35.    Ahad HA, Chinthaginjala H, Rahamtulla S, Pallavi BP, Shashanka C, Prathyusha JJAJoRiC. A Comprehensive report on Solid Dispersions by Factorial Design. 2021; 14(4):297-301.
36.    Ahad HA, Haranath C, Tarun K, et al. Vitiating Ebola Outbreak: A Brief Guide to the Humanity. 2021; 13(2):153-156.
37.    Ahad HA, Chintaginjala H, Rahamathulla S, Rupasree A, Kumar AS, Pallavi BP. Pathfinder Nanosponges for Drug Targeting by Factorial Design: A Glance Review. 2021.
38.    Jyothika LSK, Ahad HA, Haranath C, Kousar S, Sadiya SH. Types of Transdermal Drug Delivery Systems: A Literature Report of the Past decade. 2022.
39.    Ahad HA, Haranath C, Kondaveeti S, et al. Herbs in dentifrices for dental care and hygiene: a comprehensive review. 2020; 13(10):5052-5054.
40.    Obioma AJJoC, org/10.47363/JCBR/ BRSJ-Dhd. Lack of Robust Laboratory Testing Infrastructure in Nigeria: A Promoter of Community Transmission Outcome of COVID 19 Virus Indicator. 2020; 114:3.
41.    Hasan S, Saeed SJTM, Disease I. Monkeypox Disease: An Emerging Public Health Concern in the Shadow of COVID-19 Pandemic: An Update. 2022; 7(10):283.
42.    Chinthaginjala H, Ahad HA, Pradeepkumar B, et al. Formulation and In Vitro evaluation of Gastroretentive Ofloxacin floating tablets using natural polymers. 2021; 14(2):851-856.
43.    Ahad HA, Dasari RR, Haranath C, et al. Bygone exertion on mucoadhesive bilayered tablets. 2021; 14(11):5991-5992.
44.    Petersen E, Kantele A, Koopmans M, et al. Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. 2019; 33(4):1027-1043.
45.    Altindis M, Puca E, Shapo LJTM, Disease I. Diagnosis of monkeypox virus–An overview. 2022:102459.
46.    Ahad HA, Chinthaginjala H, Karar AMS, Saeed MIMA, Alawad AKAEE. Effective Management of Rare Lymphangioleiomyomatosis Using Sirolimus: Tablet Matrix with Hibiscus rosa sinensis Leave Mucilage. 2021.
47.    Ahad HA, Singh L, Chinthaginjala H, Nandyala SN, Haritha R, Chowdary AJIJoI. Operative Management and Disposal of Hospital Wastes: A Comprehensive Appraisal. 2021; 8(4).
48.    Singh L, Ahad HA, Kumar BP, Madhusudhan VJR. A Professional Opinion on the Delta AY. 4.2 Variant: A Global Threat to Humanity. 2022; 7(8):9-10.
49.    Chinthaginjala H, Ahad HA, Sumanth G, Shaik M, Dasari RRJIJoP, Research P. Hunting Hantavirus: A Quick Guide for Healthcare Professionals before It Invades the Globe unlike COVID-19. 2020:1-6.
50.    Ahad HA, Haranath C, Vikas SS, et al. A review on enzyme activated drug delivery system. 2021; 14(1):516-522.
51.    Gessain A, Nakoune E, Yazdanpanah YJNEJoM. Monkeypox. 2022.
52.    Haranath C, Jonnala R, Bhargav E, Ahad HA, Chintamaneni PKJJoYP. Clustered Regularly Interspaced Short Palindromic Repeats and its Associated Protein-9: Drug Delivery and Therapeutic Applications. 2022; 14(3):268.
53.    Khanna R, Htun HL, Li AL, et al. Staff and patient surveillance in hospitals: Good sentinels for the emergence of new SARS-CoV-2 variants. 2022; 85(4):436-480.
54.    Behrman AJJOemH, NJ, USA: Wiley-Blackwell. Occupational infections. 2011:46-74.
55.    Devi GC, Kumar AEJAJoPR. Nipah Viral Infection: An Emergency Outbreak Situation. 2018; 8(4):249-254.
56.    Ahad HA, Haranath C, Pradeepkumar B, et al. Organ Transplantation, Pros, Cons, and illustrations: A Basic Awareness to the Public. 2021; 4(1):168-174.
57.    Ahad HA, Haranath C, Roy D, Dharani BS, Raghav R, Dasari SR. A Quick Reference to The Diagnosis Test for COVID-19: Guide to Every Healthcare Professional in Global Emergencies.
58.    McCarthy MWJERoA-iT. Therapeutic strategies to address monkeypox. 2022:1-4.
59.    Ahammed SGJ, Bhupalam P, Ahad HA, et al. Black Fungus: A Lethal Communal Issue After Winning the Life Battle Against COVID-19. 2021; 14(4):2095-2101.
60.    Dehghani R, Kassiri HJRJoP, Technology. A review on epidemiology of dengue viral infection as an emerging disease. 2021; 14(4):2296-2301.
61.    Kumar YB, Ahad HA, Haranath C, Sumanth G, Pasupuleti DS, Reddy SSJIJLSPR. Platelet Rich Plasma Therapy: A quick note for every health care professional.(2020).10(5):P84-89.
62.    Batta PS, Jarugula N, Samudrala M, Manchineni PRJRJoP, Technology. A Review on Viperin Evoke Exponential Interferon Radical SAM Enzyme and Macrophages Inducibility to treat viral Infections. 2019; 12(6):3063-3067.
63.    Roess AA, Monroe BP, Kinzoni EA, et al. Assessing the effectiveness of a community intervention for monkeypox prevention in the Congo basin. 2011; 5(10):e1356.

Recomonded Articles:

Author(s): Sonam Soni, Pravin Kumar, Vinay Sagar Verma, Mukesh Sharma

DOI:         Access: Open Access Read More

Author(s): Rahamat Unissa, P. Mahesh Kumar, Gella Sunil

DOI: 10.5958/2231-5659.2019.00005.5         Access: Open Access Read More

Author(s): Mukesh Sharma, Kushagra Nagori, Shubhang Agrawal, Vinay S. Verma, Hemendra Swarnakar, Sanjay Vaishnav, Md. Nazir, Nasim Khan, Ajay Singh

DOI:         Access: Open Access Read More

Author(s): Beatrice Y. Danladi, P. Geetha

DOI: 10.5958/2231-5659.2017.00031.5         Access: Open Access Read More

Author(s): Yogita V. Dalvi

DOI: 10.5958/2231-5659.2018.00025.5         Access: Open Access Read More

Author(s): Pankaj R. Dhapake, Chauriya C.B., Umredkar R.C.

DOI: 10.5958/2231-5659.2017.00001.7         Access: Open Access Read More

Author(s): S. S. Shuka, Bina Gidwani, R. Pandey, S. P. Rao, V. Singh, Amber Vyas

DOI:         Access: Open Access Read More

Author(s): Pradeep Sahu, Neha Pinkalwar, Ravindra Dhar Dubey, Shweta Paroha, Shilpi Chatterjee, Tanushree Chatterjee

DOI:         Access: Open Access Read More

Author(s): Sable Kundan Dattatraya, Sable Kiran Dattatray, Kathwate Ganesh Sunil, Mane Snehal Suryakant

DOI: 10.5958/2231-5659.2020.00027.2         Access: Open Access Read More

Author(s): Surekha Baghel, Bina Gidwani, Chanchal Deep Kaur

DOI: 10.5958/2231-5659.2017.00009.1         Access: Open Access Read More

Author(s): Aprajita Shifali, Pravin Kumar, Vinay Pandit

DOI: 10.5958/2231-5659.2021.00012.6         Access: Open Access Read More

Author(s): P. Thamarai Selvi, M. Senthil Kumar, R. Rajesh, T. Kathiravan

DOI:         Access: Open Access Read More

Author(s): Akshay R. Yadav, Shrinivas K. Mohite, Chandrakant S. Magdum

DOI: 10.5958/2231-5659.2020.00028.4         Access: Open Access Read More

Author(s): Aashwini A. Gholkar, Yogesh P. Nikam, Krushna K. Zambare, Kavya V. Reddy, Akash D. Ghorpade

DOI: 10.5958/2231-5659.2020.00010.7         Access: Open Access Read More

Author(s): Saurabh Tiwari, Shweta Singh, Pushpendra Kumar Tripathi, Chetan Kumar Dubey

DOI: 10.5958/2231-5659.2015.00037.5         Access: Open Access Read More

Author(s): Phalguna Yadagiri, Rama Rao Korapati

DOI:         Access: Open Access Read More

Author(s): Mohammad Yaqub Khan, Irfan Aziz, Imtiyaz Ahmad, Maryada Roy

DOI: 10.5958/2231-5659.2015.00029.6         Access: Open Access Read More

Author(s): Sarmistha Rej, Madhurima Dutta, Shahid Jamal, Sumanta Das ,Sabyasachi Chatterjee

DOI:         Access: Open Access Read More

Asian Journal of Research in Pharmaceutical Sciences (AJPSci) is an international, peer-reviewed journal, devoted to pharmaceutical sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.52711/2231-5659 


Recent Articles




Tags